Відмінності між версіями «HtA. Bondue, S. T nler, and G. Chiapparo contributed equally to»

Матеріал з HistoryPedia
Перейти до: навігація, пошук
м
м
Рядок 1: Рядок 1:
−
Correspondence to C ric Blanpain: Cedric.Blanpain@ulb.ac.be Abbreviations applied in this paper: Bry, Brachyury; CM, cardiomyocyte; cTNT, cardiac troponin T; Dox, doxycyclin; EC, endothelial cell; EMT, epithelial to mesenchymal transition; EN, Engrailed; ESC, embryonic stem cell; FHF, initial heart field; MCP, multipotent [http://www.medchemexpress.com/JK184.html JK184 web] cardiovascular progenitor; PE, phosphatidylethanolamine; SHF, second heart field; SMA, smooth muscle actin; SMC, smooth muscle cell; TP, triple positive; VE, vascular endothelial.ventricle, some cells in each atria, too as cells that type the outflow tract. Bondue, S. T nler, and G. Chiapparo contributed equally to this paper. Correspondence to C ric Blanpain: Cedric.Blanpain@ulb.ac.be Abbreviations utilised in this paper: Bry, Brachyury; CM, cardiomyocyte; cTNT, cardiac troponin T; Dox, doxycyclin; EC, endothelial cell; EMT, epithelial to mesenchymal transition; EN, Engrailed; ESC, embryonic stem cell; FHF, very first heart field; MCP, multipotent cardiovascular progenitor; PE, phosphatidylethanolamine; SHF, second heart field; SMA, smooth muscle actin; SMC, smooth muscle cell; TP, triple optimistic; VE, vascular endothelial.ventricle, some cells in each atria, as well as cells that type the outflow tract. Random labeling of cardiac precursors in the course of em bryonic improvement also revealed the existence of rare clones that contributed to each FHF and SHF lineages and that could repre sent a widespread cardiovascular progenitor for each heart fields (Meilhac et al., 2004). Recent research showed that, for the duration of mouse embryonic improvement, tripotent MCPs which might be able to differen tiate at the clonal level into CMs, SMCs, and ECs could be marked and isolated according to Brachyury (Bry) and Flk1 (Kattman et al., 2006) or Isl1 and Flk1 expression (Moretti et al., 2006), whereas bipotent MCPs that give rise to CM and SMC lineages could be iso lated determined by Nkx2-5 and cKit expression (Wu et al., 2006). These studies demonstrated that cardiac cells arise from the differ entiation of multipotent progenitors, together with the ability to differenti ate at the clonal level into the distinct cardiovascular lineages (Kattman et al., 2006; Moretti et al., 2006; Wu et al., 2006).2011 Bondue et al. This article is distributed under the terms of an AttributionNoncommercial hare Alike o Mirror Web-sites license for the first six months just after the publication date (see http://www.rupress.org/terms). Soon after six months it's accessible beneath a Creative Commons License (Attribution oncommercial hare Alike 3.0 Unported license, as described at http://creativecommons.org/licenses/by-nc-sa/3.0/).The Rockefeller University Press  30.00 J. Cell Biol.HtA. Bondue, S. T nler, and G. Chiapparo contributed equally to this paper. Correspondence to C ric Blanpain: Cedric.Blanpain@ulb.ac.be Abbreviations utilized within this paper: Bry, Brachyury; CM, cardiomyocyte; cTNT, cardiac troponin T; Dox, doxycyclin; EC, endothelial cell; EMT, epithelial to mesenchymal transition; EN, Engrailed; ESC, embryonic stem cell; FHF, first heart field; MCP, multipotent cardiovascular progenitor; PE, phosphatidylethanolamine; SHF, second heart field; SMA, smooth muscle actin; SMC, smooth muscle cell; TP, triple optimistic; VE, vascular endothelial.ventricle, some cells in both atria, too as cells that kind the outflow tract. Random labeling of cardiac precursors in the course of em bryonic improvement also revealed the existence of rare clones that contributed to each FHF and SHF lineages and that could repre sent a prevalent cardiovascular progenitor for both heart fields (Meilhac et al., 2004).
+
Soon after six months it really is readily available below a Inventive Commons License (Attribution oncommercial hare Alike three.0 Unported license, as described at http://creativecommons.org/licenses/by-nc-sa/3.0/).The Rockefeller University Press  30.00 J. Cell Biol. Vol. 192 No. five 75165 www.jcb.org/cgi/doi/10.1083/jcb.JCBDuring the spontaneous differentiation of embryonic stem cells (ESCs), cardiovascular cells are generated by way of a bio [http://www.medchemexpress.com/PD166866.html PD-166866 chemical information] logical course of action that recapitulates the cellular and molecular events normally occurring throughout embryonic improvement (Kattman et al., 2007; Murry and Keller, 2008). Working with the exact same markers as to isolate the different MCPs in the course of embryonic de velopment, mouse and human bipotent and tripotent MCPs happen to be isolated through ESC differentiation, providing rise to CMs, SMCs, and ECs equivalent to their in vivo prospective (Kattman et al., 2006; Moretti et al., 2006; Wu et al., 2006; Yang et al., 2008; Bu et al., 2009). The spontaneous appearance of cardiovascular cells during the differentiation of ESCs has created wonderful enthu siasm amongst developmental biologists for studying, employing reductionist in vitro approaches, the complicated cellular and mo lecular mechanisms governing cardiovascular differentiation and cardiovascular illnesses also as offering a signifies of creating cardiovascular cells for cellular therapy and drug or toxicity screening (Murry and Keller, 2008). Mesp1 is expressed incredibly transiently in the course of early mesoderm specification within the primitive streak that migrates anterolaterally in addition to the cardiac mesoderm (Saga et.HtA. Bondue, S. T nler, and G. Chiapparo contributed equally to this paper. Correspondence to C ric Blanpain: Cedric.Blanpain@ulb.ac.be Abbreviations used within this paper: Bry, Brachyury; CM, cardiomyocyte; cTNT, cardiac troponin T; Dox, doxycyclin; EC, endothelial cell; EMT, epithelial to mesenchymal transition; EN, Engrailed; ESC, embryonic stem cell; FHF, first heart field; MCP, multipotent cardiovascular progenitor; PE, phosphatidylethanolamine; SHF, second heart field; SMA, smooth muscle actin; SMC, smooth muscle cell; TP, triple optimistic; VE, vascular endothelial.ventricle, some cells in both atria, too as cells that kind the outflow tract. Vol. 192 No. 5 75165 www.jcb.org/cgi/doi/10.1083/jcb.JCBDuring the spontaneous differentiation of embryonic stem cells (ESCs), cardiovascular cells are generated by means of a bio logical procedure that recapitulates the cellular and molecular events generally occurring throughout embryonic development (Kattman et al., 2007; Murry and Keller, 2008). Applying precisely the same markers as to isolate the diverse MCPs in the course of embryonic de velopment, mouse and human bipotent and tripotent MCPs have already been isolated through ESC differentiation, giving rise to CMs, SMCs, and ECs equivalent to their in vivo potential (Kattman et al., 2006; Moretti et al., 2006; Wu et al., 2006; Yang et al., 2008; Bu et al., 2009). The spontaneous appearance of cardiovascular cells during the differentiation of ESCs has developed excellent enthu siasm amongst developmental biologists for studying, utilizing reductionist in vitro approaches, the complex cellular and mo lecular mechanisms governing cardiovascular differentiation and cardiovascular illnesses too as offering a means of producing cardiovascular cells for cellular therapy and drug or toxicity screening (Murry and Keller, 2008). Mesp1 could be the earliest marker of cardiovascular develop ment in vivo (Saga et al., 2000; Bondue and Blanpain, 2010).

Версія за 16:05, 9 лютого 2018

Soon after six months it really is readily available below a Inventive Commons License (Attribution oncommercial hare Alike three.0 Unported license, as described at http://creativecommons.org/licenses/by-nc-sa/3.0/).The Rockefeller University Press 30.00 J. Cell Biol. Vol. 192 No. five 75165 www.jcb.org/cgi/doi/10.1083/jcb.JCBDuring the spontaneous differentiation of embryonic stem cells (ESCs), cardiovascular cells are generated by way of a bio PD-166866 chemical information logical course of action that recapitulates the cellular and molecular events normally occurring throughout embryonic improvement (Kattman et al., 2007; Murry and Keller, 2008). Working with the exact same markers as to isolate the different MCPs in the course of embryonic de velopment, mouse and human bipotent and tripotent MCPs happen to be isolated through ESC differentiation, providing rise to CMs, SMCs, and ECs equivalent to their in vivo prospective (Kattman et al., 2006; Moretti et al., 2006; Wu et al., 2006; Yang et al., 2008; Bu et al., 2009). The spontaneous appearance of cardiovascular cells during the differentiation of ESCs has created wonderful enthu siasm amongst developmental biologists for studying, employing reductionist in vitro approaches, the complicated cellular and mo lecular mechanisms governing cardiovascular differentiation and cardiovascular illnesses also as offering a signifies of creating cardiovascular cells for cellular therapy and drug or toxicity screening (Murry and Keller, 2008). Mesp1 is expressed incredibly transiently in the course of early mesoderm specification within the primitive streak that migrates anterolaterally in addition to the cardiac mesoderm (Saga et.HtA. Bondue, S. T nler, and G. Chiapparo contributed equally to this paper. Correspondence to C ric Blanpain: Cedric.Blanpain@ulb.ac.be Abbreviations used within this paper: Bry, Brachyury; CM, cardiomyocyte; cTNT, cardiac troponin T; Dox, doxycyclin; EC, endothelial cell; EMT, epithelial to mesenchymal transition; EN, Engrailed; ESC, embryonic stem cell; FHF, first heart field; MCP, multipotent cardiovascular progenitor; PE, phosphatidylethanolamine; SHF, second heart field; SMA, smooth muscle actin; SMC, smooth muscle cell; TP, triple optimistic; VE, vascular endothelial.ventricle, some cells in both atria, too as cells that kind the outflow tract. Vol. 192 No. 5 75165 www.jcb.org/cgi/doi/10.1083/jcb.JCBDuring the spontaneous differentiation of embryonic stem cells (ESCs), cardiovascular cells are generated by means of a bio logical procedure that recapitulates the cellular and molecular events generally occurring throughout embryonic development (Kattman et al., 2007; Murry and Keller, 2008). Applying precisely the same markers as to isolate the diverse MCPs in the course of embryonic de velopment, mouse and human bipotent and tripotent MCPs have already been isolated through ESC differentiation, giving rise to CMs, SMCs, and ECs equivalent to their in vivo potential (Kattman et al., 2006; Moretti et al., 2006; Wu et al., 2006; Yang et al., 2008; Bu et al., 2009). The spontaneous appearance of cardiovascular cells during the differentiation of ESCs has developed excellent enthu siasm amongst developmental biologists for studying, utilizing reductionist in vitro approaches, the complex cellular and mo lecular mechanisms governing cardiovascular differentiation and cardiovascular illnesses too as offering a means of producing cardiovascular cells for cellular therapy and drug or toxicity screening (Murry and Keller, 2008). Mesp1 could be the earliest marker of cardiovascular develop ment in vivo (Saga et al., 2000; Bondue and Blanpain, 2010).

Отримано з http://istoriya.soippo.edu.ua/index.php?title=HtA._Bondue,_S._T_nler,_and_G._Chiapparo_contributed_equally_to&oldid=285986